Results 211 to 220 of about 91,972 (285)

Relation Between Myasthenia Gravis and Thyroid Disease [PDF]

open access: bronze, 1965
B. M. Sahay   +2 more
openalex   +1 more source

Improvement in Patient‐Reported Symptoms of Generalised Myasthenia Gravis With Rozanolixizumab in the Randomised Phase 3 MycarinG Study Using the MG Symptoms PRO

open access: yesEuropean Journal of Neurology, Volume 32, Issue 8, August 2025.
ABSTRACT Background In the Phase 3 MycarinG study (NCT03971422), rozanolixizumab improved myasthenia gravis (MG)‐specific outcomes versus placebo in patients with generalised MG, including those measured by the five independent MG Symptoms patient‐reported outcome (PRO) scales: Muscle Weakness Fatigability (MWF), Physical Fatigue (PF) and Bulbar Muscle
Henry J. Kaminski   +12 more
wiley   +1 more source

Efgartigimod as a Fast‐Acting Add‐On Therapy in Antibody–Mediated Autoimmune Encephalitis

open access: yesEuropean Journal of Neurology, Volume 32, Issue 8, August 2025.
ABSTRACT Background Autoimmune encephalitis (AE) is a severe neurological disorder that requires effective and safe treatment options. This study aimed to compare the efficacy and safety of intravenous methylprednisolone (IVMP) plus efgartigimod (IPE) versus IVMP alone or IVMP plus immunoglobulin (IPI) as initial treatments for antibody‐mediated AE ...
Zhuajin Bi   +4 more
wiley   +1 more source

Myasthenia Gravis in a Patient with Chronic Myeloid Leukemia Treated by Busulfan [PDF]

open access: bronze, 1968
M Djaldetti   +5 more
openalex   +1 more source

Family Game Show-style Didactic for Teaching Nervous System Disorders during Emergency Medicine Training [PDF]

open access: yes, 2020
Boysen Osborn, Megan   +3 more
core  

Efgartigimod as Add‐On Treatment in Refractory Guillain–Barré Syndrome: A Case Report

open access: yesEuropean Journal of Neurology, Volume 32, Issue 8, August 2025.
ABSTRACT Background and Aims Guillain–Barré Syndrome (GBS) is an autoimmune disease that can cause flaccid tetraplegia. Efgartigimod, a monoclonal antibody that inhibits the neonatal receptor (FcRn), increases IgG degradation. Methods A 60‐year‐old lady was admitted with acute flaccid tetraparesis, requiring mechanical ventilation within 12 h.
P. Ripellino   +6 more
wiley   +1 more source

Neonatal Myasthenia Gravis [PDF]

open access: bronze, 1964
G M Stern, J. M. Hall, Dwicht Robinson
openalex   +1 more source

Beyond the Surface: Investigating the Potential Mechanisms of Non‐Motor Symptoms in Myasthenia Gravis

open access: yesEuropean Journal of Neurology, Volume 32, Issue 8, August 2025.
We review the non‐motor symptoms of MG and their potential pathogenesis, hoping to contribute to personalized diagnosis and treatment. ABSTRACT Background Myasthenia gravis (MG) is an autoimmune disorder affecting the neuromuscular junction (NMJ), driven by T cells, mediated by B cells, and dependent on autoantibodies.
Benqiao Wang   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy